TWD 22.75
(-19.04%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 31.8 Million TWD | -20.43% |
2022 | 39.97 Million TWD | 276.21% |
2021 | -22.68 Million TWD | 80.19% |
2020 | -114.53 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 11.15 Million TWD | -64.93% |
2023 FY | 31.8 Million TWD | -20.43% |
2023 Q4 | 31.8 Million TWD | 2732.5% |
2023 Q2 | 1.12 Million TWD | -97.19% |
2022 Q4 | 39.97 Million TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 141.287% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 112.041% |
Level Biotechnology Inc. | -453.9 Million TWD | 107.008% |
Sagittarius Life Science Corp | -120.57 Million TWD | 126.382% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 116.196% |
TaiMed Biologics Inc. | 499.84 Million TWD | 93.636% |
GlycoNex Incorporation | -148.56 Million TWD | 121.411% |
VBI | -25.31 Million TWD | 225.648% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 21.003% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 76.949% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 112.114% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -4.026% |
Visgeneer Inc. | 31.28 Million TWD | -1.678% |
Mycenax Biotech Inc. | 207 Million TWD | 84.634% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 104.674% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 123.694% |
Neith Corporation | -150.31 Million TWD | 121.162% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 94.882% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 155.168% |
Enimmune corporation | -314.15 Million TWD | 110.125% |
TaiRx, Inc. | -147.86 Million TWD | 121.512% |
CHO Pharma, Inc. | -203.79 Million TWD | 115.609% |
EirGenix Inc. | -4.58 Billion TWD | 100.693% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 137.527% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 73.684% |
Lin BioScience, Inc. | -3.21 Billion TWD | 100.988% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 110.021% |
Feng Chi Biotech Corp. | -19.81 Million TWD | 260.546% |
Lukas Biomedical Inc. | 50.75 Million TWD | 37.328% |
RBC Bioscience Corporation | 422.18 Million TWD | 92.466% |
BiOptic Inc. | 12.59 Million TWD | -152.613% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 103.368% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 131.343% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 119.258% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 89.898% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 149.454% |
NaviFUS Corp. | -123.12 Million TWD | 125.834% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 57.044% |
Sinew Pharma Inc. | -160.34 Million TWD | 119.838% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 113.15% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 109.428% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 107.709% |
AP Biosciences Inc | -196.52 Million TWD | 116.185% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 95.382% |
3D Global Biotech Inc. | -11.43 Million TWD | 378.124% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 103.834% |
Intech Biopharm Corporation | 1.35 Billion TWD | 97.656% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 107.667% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 115.195% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 122.111% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 109.623% |
TCI GENE Inc. | -689.25 Million TWD | 104.615% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 126.744% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 102.43% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -55.295% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 131.225% |
PharmaEngine, Inc. | -860.8 Million TWD | 103.695% |
Savior Lifetec Corporation | -812.54 Million TWD | 103.915% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 110.604% |
OBI Pharma, Inc. | -398.22 Million TWD | 107.988% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 108.705% |
Acepodia, Inc. | -6.02 Billion TWD | 100.528% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 100.935% |